Bank Of New York Mellon Corp Uro Gen Pharma Ltd. Transaction History

Bank Of New York Mellon Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.12 - $8.74 $345,528 - $589,827	-67,486 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$5.92 - $9.73 $42,606 - $70,026	7,197 Added 11.94%	67,486 $588,000
Q4 2021 Feb 11, 2022	SELL	$9.03 - $19.13 $9,436 - $19,990	-1,045 Reduced 1.7%	60,289 $573,000
Q3 2021 Nov 12, 2021	BUY	$14.31 - $18.39 $75,513 - $97,044	5,277 Added 9.41%	61,334 $1.03 Million
Q2 2021 Aug 11, 2021	BUY	$15.2 - $20.94 $45,995 - $63,364	3,026 Added 5.71%	56,057 $855,000

Q1 2021 May 13, 2021	BUY	$17.99 - $26.96 $20,598 - $30,869	1,145 Added 2.21%	53,031 $1.03 Million
Q4 2020 Feb 09, 2021	SELL	$17.54 - $25.43 $32,747 - $47,477	-1,867 Reduced 3.47%	51,886 $934,000
Q3 2020 Nov 12, 2020	SELL	$18.81 - $26.42 $29,343 - $41,215	-1,560 Reduced 2.82%	53,753 $1.04 Million
Q2 2020 Aug 12, 2020	BUY	$16.5 - $29.7 $117,430 - $211,374	7,117 Added 14.77%	55,313 $1.44 Million
Q1 2020 May 06, 2020	SELL	$13.68 - $34.6 $533 - $1,349	-39 Reduced 0.08%	48,196 $859,000
Q4 2019 Feb 14, 2020	BUY	$21.11 - $34.86 $42,051 - $69,441	1,992 Added 4.31%	48,235 $1.61 Million
Q3 2019 Nov 07, 2019	BUY	$23.83 - $36.44 $42,774 - $65,409	1,795 Added 4.04%	46,243 $1.1 Million
Q2 2019 Aug 12, 2019	BUY	$32.75 - $40.35 $1.46 Million - $1.79 Million	44,448 New	44,448 $1.6 Million
Q4 2018 Feb 11, 2019	SELL	$38.35 - $50.39 $342,197 - $449,629	-8,923 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$41.65 - $51.7 $371,642 - $461,319	8,923 New	8,923 $0

113

24M

46.9K

44.3K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $373M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.